Abstract
Background: Regorafenib is a multikinase inhibitor, indicated for the treatment of metastatic colorectal cancer and locally advanced, unresectable or metastatic gastrointestinal stromal tumor.
Objective: A simple and fast, validated bioanalytical method is required for pre-clinical or clinical safety and efficacy investigations and possible pharmacokinetic interaction of regorafenib.
Method: Regorafenib and sorafenib were eluted on Acquity UPLC®BEH C18 column. Elution was carried out by pumping mobile phase [methanol (0.1% formic acid): water (85:15%)] at 200µl/min flow rate. Mass detector was operated in multiple-reaction monitoring mode. Deprotonated ions [M-H]- of regorafenib and sorafenib were fragmented and monitored.
Results: Daughter fragments of regorafenib (m/z 481.1 > 194, m/z 481.1 > 260) and sorafenib (m/z 463 > 193.99, m/z 463 > 268.1) were determined in negative electrospray ionization mode. Linear calibration curve of range 50-2500 ng/ml was prepared in plasma. Method was selective, since there was no interfering peak at regorafenib retention time. Coefficients of variation for inter-day precision at three quality control concentrations were 17.6% at lower limit of quantitation, 6.3% at middle limit, and 2.9% at the highest limit of quantitation. Accuracy of the method ranged between 96% to 105.3%. Recovery of drug from blank plasma at quality control concentrations varied between 82.53 to 105.66%.
Conclusion: The developed method was successfully validated by adopting US FDA guidance for bioanalytical methods. The method is simple, quick and can be adopted for regorafenib estimation in other biological fluids with necessary modifications.
Keywords: Regorafenib, sorafenib, pharmacokinetics, bioanalysis, UPLC-MS/MS, elution.
Current Analytical Chemistry
Title:Rapid UPLC Tandem Triple Quadrupole Mass Spectrometry Method for Determination of Regorafenib in Plasma
Volume: 14 Issue: 6
Author(s): Mohd Aftab Alam*, Fahad Ibrahim Al-Jenoobi, Ahmed Abdelrahman Abdelgalil and Abdullah Mohammed Al-Mohizea
Affiliation:
- Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh,Saudi Arabia
Keywords: Regorafenib, sorafenib, pharmacokinetics, bioanalysis, UPLC-MS/MS, elution.
Abstract: Background: Regorafenib is a multikinase inhibitor, indicated for the treatment of metastatic colorectal cancer and locally advanced, unresectable or metastatic gastrointestinal stromal tumor.
Objective: A simple and fast, validated bioanalytical method is required for pre-clinical or clinical safety and efficacy investigations and possible pharmacokinetic interaction of regorafenib.
Method: Regorafenib and sorafenib were eluted on Acquity UPLC®BEH C18 column. Elution was carried out by pumping mobile phase [methanol (0.1% formic acid): water (85:15%)] at 200µl/min flow rate. Mass detector was operated in multiple-reaction monitoring mode. Deprotonated ions [M-H]- of regorafenib and sorafenib were fragmented and monitored.
Results: Daughter fragments of regorafenib (m/z 481.1 > 194, m/z 481.1 > 260) and sorafenib (m/z 463 > 193.99, m/z 463 > 268.1) were determined in negative electrospray ionization mode. Linear calibration curve of range 50-2500 ng/ml was prepared in plasma. Method was selective, since there was no interfering peak at regorafenib retention time. Coefficients of variation for inter-day precision at three quality control concentrations were 17.6% at lower limit of quantitation, 6.3% at middle limit, and 2.9% at the highest limit of quantitation. Accuracy of the method ranged between 96% to 105.3%. Recovery of drug from blank plasma at quality control concentrations varied between 82.53 to 105.66%.
Conclusion: The developed method was successfully validated by adopting US FDA guidance for bioanalytical methods. The method is simple, quick and can be adopted for regorafenib estimation in other biological fluids with necessary modifications.
Export Options
About this article
Cite this article as:
Alam Aftab Mohd*, Al-Jenoobi Ibrahim Fahad, Abdelgalil Abdelrahman Ahmed and Al-Mohizea Mohammed Abdullah, Rapid UPLC Tandem Triple Quadrupole Mass Spectrometry Method for Determination of Regorafenib in Plasma, Current Analytical Chemistry 2018; 14 (6) . https://dx.doi.org/10.2174/1573411014666171204155553
DOI https://dx.doi.org/10.2174/1573411014666171204155553 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
Call for Papers in Thematic Issues
Advancements in biomedicine, corrosion inhibition/monitoring, and lubrication of carbon dots
Carbon dots, a class of carbon-based nanomaterials, have garnered substantial interest in various scientific and engineering fields due to their unique properties, including excellent optical properties, outstanding biocompatibility, easy preparation, good dispersity, ultrasmall size, low toxicity and environmental friendliness. This special issue of Current Analytical Chemistry aims to showcase cutting-edge ...read more
Analytical methods for environmental and food analysis
In recent years, the study of the chemical composition of food and the environment depends on analytical methods in order to acquire information about the chemical composition, processing, quality control and contamination of soil, water, air, plants and foods, aspects very important for food safety and environmental quality control. There ...read more
Applications of artificial intelligence in chemical analysis
Artificial intelligence (AI) has demonstrated its versatility in almost all scientific fields, especially analytical chemistry, which is leading the way in the integration of AI. According to Chemical Abstract Services, one of the major disciplines contributing to AI-related publications and patents is analytical chemistry. That?s because techniques such as deep ...read more
Bioanalytical and Biosensor Technologies for Target Molecules
Bioanalytical and biosensor technologies constitute the core of detecting and sensing diverse molecules within living organisms, encompassing proteins, DNA, small molecular metabolites, and beyond. These molecules assume pivotal roles in biological processes, rendering their analysis and sensing indispensable for comprehending biological phenomena and unraveling disease mechanisms. In the current landscape ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Conotoxins: Review and Docking Studies to determine potentials of Conotoxin as an Anticancer Drug Molecule
Current Topics in Medicinal Chemistry Signalling Pathways Activated by Ultraviolet Radiation: Role in Ocular and Cutaneous Health
Current Pharmaceutical Design Understanding and Applying Personalized Therapeutics at Systems Level:Role for Translational Bioinformatics
Current Pharmacogenomics and Personalized Medicine Progress of Individualized Chemotherapy for Gastric Carcinoma Under the Guidance of Genetic Testing
Current Medicinal Chemistry Titanocene Y - Transport and Targeting of an Anticancer Drug Candidate
Letters in Drug Design & Discovery A Potent Anti-Carcinoma and Anti-Acute Myeloblastic Leukemia Agent, AG490
Anti-Cancer Agents in Medicinal Chemistry Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution
Current Molecular Medicine The Role of Sensing Peptides in the Cross-talk between Microbiota and Human Cancer Cells
Mini-Reviews in Medicinal Chemistry Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment
Current Cancer Drug Targets Targeting RAS Signaling Pathways in Juvenile Myelomonocytic Leukemia
Current Drug Targets Editorial
Current Cancer Therapy Reviews Approaching the Increasing Complexity of Non-small Cell Lung Cancer Taxonomy
Current Pharmaceutical Design Mechanism of Drug Sensitivity and Resistance in Melanoma
Current Cancer Drug Targets CRH Receptor Signalling: Potential Roles in Pathophysiology
Current Molecular Pharmacology Diastereoselective Addition of Organometallic Reagents to Diimines Derived from (R,R)-1,2-Diaminocyclohexane and Aromatic Aldehydes
Letters in Organic Chemistry Urinary Tract Tumors, Biology and Risk for Artificial Sweeteners Use with Particular Emphasis on some South American Countries
Current Nutrition & Food Science Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Current Pharmacological Approaches to Prevent and Treat Post- Menopausal Osteoporosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Comprehensive Profiling of the Low Molecular Weight Proteins and Peptides in Weak Cation Exchange Beads Human Serum Retentate
Protein & Peptide Letters Implication of CYP24A1 Splicing in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry